-
Symbol
-
QCLS on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
8,475,368 shares
-
Security Ownership %
-
74%
PharmaCyte Biotech, Inc. ownership in Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS)
18 Nov 2025 - PharmaCyte Biotech, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,475,368 shares of Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS).
This represents 74% ownership of the company.
This is the first filing by PharmaCyte Biotech, Inc. disclosing ownership of Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS).